Can You Take Meloxicam with Prednisone?
No, combining meloxicam (an NSAID) with prednisone (a corticosteroid) is generally not recommended without close medical supervision. Both drugs suppress inflammation but increase risks of gastrointestinal bleeding, ulcers, and perforation—sometimes without warning symptoms.[1][2] Drug interaction checkers like Drugs.com flag this as a major interaction, advising avoidance or dose adjustments.[3]
What Are the Main Risks?
The combo heightens GI issues because NSAIDs like meloxicam damage the stomach lining while steroids like prednisone impair healing and raise acid production. Other concerns include elevated blood pressure, kidney strain, and fluid retention. A 2017 review in Therapeutic Advances in Musculoskeletal Disease noted up to 15-fold increased ulcer risk with concurrent use.[4] Elderly patients or those with ulcer history face higher odds.
When Might Doctors Prescribe Them Together?
Physicians sometimes co-prescribe short-term for severe conditions like rheumatoid arthritis flares, adding a proton pump inhibitor (e.g., omeprazole) for stomach protection. Always get personalized advice—don't self-medicate.[1][5]
What Should You Do If You're Already Taking Both?
Contact your doctor or pharmacist immediately. They may taper one drug, monitor via endoscopy, or switch alternatives. Symptoms like black stools, severe abdominal pain, or vomiting blood demand emergency care.[2]
Safer Alternatives to This Combo?
- For pain/inflammation: Switch to acetaminophen (Tylenol) if suitable, or low-dose celecoxib (Celebrex), which may carry lower GI risk than meloxicam.[6]
- Steroid-sparing options: Disease-modifying drugs like methotrexate for autoimmune issues.
- Non-drug: Physical therapy, ice/heat, or topical NSAIDs.
Discuss your full med list and conditions with a healthcare provider for tailored swaps.
Sources
[1] Meloxicam (Mobic) FDA Label
[2] Prednisone FDA Label
[3] Drugs.com Interaction Checker
[4] Ther Adv Musculoskelet Dis (2017)
[5] UpToDate: NSAIDs
[6] Celecoxib GI Risk Study (NCBI)